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Knowledge about the molecular mechanisms driving Alzheimer’s disease (AD) is still limited. To learn
more about AD biology, we performed whole transcriptome sequencing on the hippocampus of 20 AD
cases and 10 age- and sex-matched cognitively healthy controls. We observed 2716 differentially
expressed genes, of which 48% replicated in a second data set of 84 AD cases and 33 controls. We used an
integrative network-based approach for combining transcriptomic and protein-protein interaction data
to ﬁnd differentially expressed gene modules that may reﬂect key processes in AD biology. A total of 735
differentially expressed genes were clustered into 33 modules, of which 82% replicated in a second data
set, highlighting the robustness of this approach. These 27 modules were enriched for signal trans-
duction, transport, response to stimulus, and several organic and cellular metabolic pathways. Ten
modules interacted with previously described AD genes. Our study indicates that analyzing RNA-
expression data based on annotated gene modules is more robust than on individual genes. We pro-
vide a comprehensive overview of the biological processes involved in AD, and the detected differentially
expressed gene modules may provide a molecular basis for future research into mechanisms underlying
AD.
 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder hall-
marked by progressive loss of memory, currently affecting over 40
million individuals worldwide (Prince et al., 2013; Scheltens et al.,
2016). Previous studies have shown neurodegenerative changes in
the hippocampus 15e20 years before symptom onset (Boyle et al.,
2013; Karran et al., 2011; Murray et al., 2011). Themain pathological
features are amyloid plaques and tau tangles throughout the brain
(Braak and Braak, 1995; Holtzman et al., 2016; Jellinger, 2008;
Selkoe and Hardy, 2016; Thal et al., 2014; Tomiyama, 2010). Mul-
tiple AD-associated genetic loci have been identiﬁed, although theirgy, Erasmus Medical Center,
am, the Netherlands. Tel.:
Rooij).
Inc. This is an open access article upathophysiological mechanisms remain largely unknown (Bekris
et al., 2010; Lambert et al., 2013; Van Cauwenberghe et al., 2016).
Transcriptomic studies on postmortem AD brain tissue have
been performed to further our understanding of AD biology
(Kavanagh et al., 2013; Sutherland et al., 2011). Most of these
studies report differentially expressed genes and pathways in brain
tissue of AD cases compared with controls (Ashburner et al., 2000;
Gene Ontology, 2015; Ogata et al., 1999). Most of these studies
report a decrease in synaptic transmission, mitochondrial function,
and cytoskeleton biology. By contrast, an increase is often reported
in immune response, inﬂammation, and apoptosis in AD cases
(Liang et al., 2008; Ray and Zhang, 2010; Sekar et al., 2015; Twine
et al., 2011). Recently, network-based analysis are used to provide
more extensive and robust insights in these data, for example,
based on protein-protein interaction (PPI) data (Chi et al., 2016; C.
Humphries et al., 2015; C.E. Humphries et al., 2015; Kong et al.,
2014, 2015). The largest among these studies investigated genender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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brain samples, spread across 19 regions in 125 individuals (Wang
et al., 2016). By performing gene coexpression analysis on AD
cases of varying severity and nondemented controls, they identiﬁed
dysregulated gene modules and pathways. The study concluded
that some of those originated from early disease stages and might
reﬂect causal mechanisms, but also highlighted to use of gene
modules rather than individual genes. In this study, these modules
are based on only coexpression type PPI data.
The goal of our study was to compare whole transcriptome
sequencing of 20 AD cases with 10 age- and sex-matched cogni-
tively healthy controls. We aim to identify differentially expressed
genes and cluster these into functional gene modules using PPI
data. We aim to replicate these differentially expressed genes, gene
modules, and functions in a second independent RNA sequencing
data set (van der Brug et al., 2017) to determine the robustness of
replication based on gene modules compared with individual
genes.
2. Materials and methods
2.1. Data generation
Hippocampus samples were selected from the Netherlands
Brain Bank for 20 AD cases (Braak and Braak, 1995; Mirra et al.,
1991) and matched for age and gender with brains from 10 non-
demented cognitively healthy controls (Table 1). The dentate gyrus
and cornu amonis were macrodissected from the hippocampus
tissue, and total RNAwas isolated using themanufacturer’s protocol
(Qiagen AllPrep RNA isolation, Cat No. 80224). Sequencing was
performed after poly-A selection and TruSeq library prep at the
Human Genomics facility (www.glimdna.org) on a HiSeq2000 at
2  50 bp. Data were processed per sample using trim-o-matic
(v0.33), STAR (v2.3.0) (Bolger et al., 2014; Dobin et al., 2013), pic-
ard (v1.90), and fastQC (v0.11.3). Transcript quantiﬁcation was
performed using featureCounts (v1.4.3) against all 57,820 gene
features in GENCODE (version date; 2013-12-05) (Harrow et al.,
2012; Liao et al., 2014). For replication, data set GSE95587 was
downloaded from the Gene Expression Omnibus. This data set
contained raw RNA-seq counts of the fusiform gyrus for 84 AD cases
and 33 controls and was processed in parallel to the discovery data
set in all subsequent steps (van der Brug et al., 2017).
2.2. Data analysis
Counts were normalized using the edgeR (v3.8.6) trimmed
mean of M-values method to counts per million values, and all low-
abundant features were omitted (<1 counts per million in 75% of
samples). Principal components (PCs) were calculated using
“prcomp” in R, and then plotted to visually identify sample outliers.Table 1
Study sample characteristics
Characteristic Controls Cases Cases_QC
Number 10 20 18
Gender (% male) 50% 30% 44%
Age (SD) 76  12 75  7 75  7
Braak 1.5  1.3 5.5  0.5* 5.6  0.5*
Amyloid 0.9  1.1 2.9  0.3* 2.9  0.3*
pmd 551  297 348  108* 329  98*
pH 6.6  0.3 6.3  0.3* 6.3  0.3*
Brain weight 1319  240 1045  119* 1035  113*
apoe (32/33/44) 4/6/0 1/9/10* 1/8/9*
An asterisk denotes statistically signiﬁcant difference compared with controls.
All values represent means with standard deviations unless otherwise indicated.
“Cases_QC” indicates metrics after removing two outlier cases.Statistical analysis was performed per gene using the exacTest
function in edgeR, correcting for age, gender, and the ﬁrst 2 PCs
(McCarthy et al., 2012; Robinson et al., 2010). We combined FDR-
corrected p-values and log fold changes to calculate a differential
expression score; log10pðFDRÞ10 *
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
logFC*logFC
p
3 . Genes with a differentially
expressed score0.10 are considered differentially expressed genes
(DE genes) and retained for further analysis. All steps were per-
formed identically and separately for the discovery and replication
data sets Table 2.2.3. Protein-protein interaction clustering
For all DE genes, we extracted experimental, coexpression, and
database interactions scored 500 from STRING v10 (von Mering
et al., 2003). This network was imported to Cytoscape (v3.4.0)
and subjected to the Markov Clustering Algorithm (MCL) to identify
gene modules (Morris et al., 2011; Smoot et al., 2011). In short, MCL
clusters graphical data to determine groups of genes (modules)
with more interactions within the module than to the rest of the
network (Enright et al., 2002). This clustering method revolves
around one main parameter which determines the module sizes;
the inﬂation factor. We optimized the inﬂation factor to retain
modules between 10e100 genes to allow for subsequent gene set
enrichment analysis (Subramanian et al., 2005). Each gene can only
be assigned to a single module. Modules smaller than 10 genes are
excluded. All steps are performed separately for the discovery and
replication data set.2.4. Functional annotation of modules
For each identiﬁed gene module, enrichments for gene
ontology biological processes (GOBPs) were performed using
WebGestalt (v27-1-17) (Gene Ontology, 2001; Ogata et al., 1999).
For GOBP enrichment the “noRedundant” terms were used. All
enrichments were FDR (Benjamini-Hochberg) corrected, using a
threshold of p < 0.05 for statistical signiﬁcance. Only the ﬁrst
three enriched GOBP terms were extracted for each gene module.
All three GOBP terms for all gene modules were then pooled and
divided into shared common ancestor terms, denoted as GOBP
branches (Ashburner et al., 2000; Carbon et al., 2009). Therefore,
each gene module can be annotated with three GOBP terms and
their respective GOBP branch. Modules from discovery and
replication are divided in to the same GOBP branches. They can
thus be enriched for the same GOBP term or enriched for different
GOBP terms that are closely related by sharing a common
ancestor term.2.5. Replication of DE genes and modules
DE genes and gene modules were generated separately for the
discovery and replication data sets using the exact same method-
ology. Replication of discovery modules is assessed by the number
of overlapping genes and overlapping GOBP terms within the
replication modules. Different degrees of robustness of overlap
between our data and the replication data set were classiﬁed.
Category (1) a gene module overlaps in genes and in GOBP term(s)
with a gene module from the replication data set. Category (2) a
gene module overlaps in GOBP term(s), but not in genes with a
replication module. Category (3) a gene module overlaps in genes
with a replicationmodule, but not in GOBP term(s). When amodule
from discovery shares a parent GOBP term with a replication
module this was also considered replication.
Table 2
Overview of all three gene ontology biological processes of the discovery modules
Discovery
module
Number of
genes
GOBP
branch
GOBP term Replication module AD genes
M1 90 2 G-proteinecoupled receptor signaling pathway,
coupled to cyclic nucleotide second messenger
R1 APP
2 Phospholipase C-activating G-proteinecoupled
receptor signaling pathway
R1
2 Neuropeptide signaling pathway R1, R7, R35
M2 52 9 Multicellular organismal signaling R10 MAPT, ABCA7
3 Divalent inorganic cation transport R10
4 Regulation of transmembrane transport R10, R18
M3 39 1 DNA-templated transcription, initiation R2
8 Response to type I interferon -
8 Response to interferon-gamma -
M4 35 1 Macromolecule deacylation R3
1 Histone modiﬁcation R3
4 Regulation of chromatin organization -
M5 32 4 Potassium ion transport R18
4 Regulation of transmembrane transport R10, R18
6 Protein oligomerization R18
M6 31 4 Regulation of small GTPase mediated signal transduction R5
2 Ras protein signal transduction R5
4 Regulation of cell morphogenesis -
M7 30 2 Glutamate receptor signaling pathway R35 PTK2B
4 Modulation of synaptic transmission -
9 Neuromuscular process -
M8 29 5 mRNA processing R17 CELF1
1 Peptidyl-threonine modiﬁcation R15
5 RNA splicing R17
M9 27 3 Receptor-mediated endocytosis - BIN1, HLA-DRB1,
HLA-DRB5, PICALM9 Microtubule-based movement -
4 Regulation of response to biotic stimulus R12
M10 26 2 Integrin-mediated signaling pathway R4
6 Extracellular structure organization R4
9 Cell-substrate adhesion -
M11 21 1 Peptidyl-tyrosine modiﬁcation R19, R25
6 Axon development -
1 Ephrin receptor signaling pathway R25
M12 22 1 DNA replication R36
1 DNA repair R22, R36
1 DNA recombination R22, R36
M13 20 - - -
- - -
- - -
M14 19 3 Exocytosis R27 CLU
9 Actin ﬁlament-based movement R34
6 Actin ﬁlament organization R37
M15 19 5 Dephosphorylation -
5 RNA splicing R17
9 Meiotic cell cycle -
M16 18 3 Synaptic vesicle cycle -
3 Exocytosis R27
3 Neurotransmitter transport -
M17 17 8 Stress-activated protein kinase signaling cascade -
4 Positive regulation of MAPK cascade -
4 Positive regulation of kinase activity R9
M18 18 2 I-kappaB kinase/NF-kappaB signaling R12, R23
8 Cellular response to biotic stimulus R23
9 Type I interferon production -
M19 17 1 Translational elongation -
1 Mitochondrial translation -
6 Macromolecular complex disassembly -
M20 17 3 Inorganic anion transport R7
3 Anion transmembrane transport R7
2 Gamma-aminobutyric acid signaling pathway R7
M21 15 3 Transition metal ion transport R24
3 Hydrogen transport R18
7 Autophagy -
M22 15 6 NADH dehydrogenase complex assembly -
6 Mitochondrial respiratory chain complex assembly -
9 Mitochondrial respiratory chain complex I biogenesis -
M23 14 7 Multicellular organism metabolic process R4
6 Extracellular structure organization R4
- - -
(continued on next page)
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Table 2 (continued )
Discovery
module
Number of
genes
GOBP
branch
GOBP term Replication module AD genes
M24 13 7 Glycerolipid metabolic process -
7 Lipid modiﬁcation -
5 Phospholipid metabolic process -
M25 13 1 Peptidyl-serine modiﬁcation R15, R19, R25
- - -
- - -
M26 12 1 Protein ubiquitination involved in
ubiquitin-dependent protein catabolic process
-
1 Protein polyubiquitination -
7 Amine metabolic process R20
M27 12 9 Neuron projection guidance R34
- - -
- - -
M28 11 5 Organophosphate catabolic process -
1 Carbohydrate derivative catabolic process R13
5 Aromatic compound catabolic process -
M29 11 - - -
- - -
- - -
M30 10 5 Pyruvate metabolic process R32
7 Small molecule catabolic process -
7 Carbohydrate catabolic process -
M31 10 - - -
- - -
- - -
M32 10 3 Mitochondrial transport R8
5 Nucleoside monophosphate metabolic process R13
3 Hydrogen transport R18
M33 10 6 Chromatin remodeling R3
9 Protein acylation R3
- - -
Per module, the number of genes is shown. For each term, the name and respective GOBP branch is shown. The column “replication module” indicates which replication
module also had this GOBP term. The last column indicates interaction of discovery module with known AD genes.
Key: GOBP, gene ontology biological process; AD, Alzheimer’s disease.
Fig. 1. Flowchart of data analysis. Discovery and replication data set are analyzed and
differentially expressed genes are determined. An interaction network is constructed
for each data set, which is then clustered in gene modules. These modules are
compared directly on overlapping genes and on enriched gene ontology biological
processes. Interactions of modules identiﬁed in discovery with known AD genes are
also investigated. Abbreviations: AD, Alzheimer’s disease.
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We selected a list of 27 known AD risk genes, compiled from
known AD GWAS loci and Mendelian causal genes (Lambert et al.,
2013; Van Cauwenberghe et al., 2016). All experimental and data-
base interactions between these 27 AD genes and the genes in
discovery modules were extracted from STRING, using a cutoff of
500. An AD gene was considered to interact with a discovery
module when it interacted with at least two of the genes in that
module.
3. Results
3.1. Study sample characteristics
The demographic data of the AD group did not differ from the
control group, as shown in Table 1. As expected, mean brainweight,
Braak and CERAD stages and postmortem delay differed signiﬁ-
cantly between AD cases and controls. On average, 48,772,000
reads were sequenced per sample. All sequencing quality and
alignment QC metrics were similar between groups. Two outliers
were identiﬁed by PCs, driven by high expression of TTR. This gene
is speciﬁcally expressed in the choroid plexus, which was
conﬁrmed using routine staining and both cases were excluded. The
replication data set GSE95587 consisted of fusiform gyrus from 84
AD cases and 33 controls and is described elsewhere (van der Brug
et al., 2017).
3.2. Differentially expressed genes and modules
A total of 2716 genes was differentially expressed in the dis-
covery data set (DE score 0.1), as shown in Fig. 1. Examination of
J.G.J. van Rooij et al. / Neurobiology of Aging 74 (2019) 225e233 229known interactions between these DE genes showed that 1610 DE
genes shared one or more interaction(s). Using this interaction
network, we clustered 735 discovery DE genes into 33 discovery
gene modules. The expression table and gene-module assign-
ments can be found in supplemental Table 1. In the replication
data set, 2490 DE genes were identiﬁed. A total of 1311 DE genes
from the discovery data set (48%) replicated in the replication
data set, as shown in Fig. 2. From the interaction network of
replication DE genes, 653 DE genes were clustered into 37 repli-
cation modules.Fig. 2. Volcano plot of 14,564 analyzed protein-coding genes. Each dot is a gene, those dar
displayed by dotted lines. The solid line displays the default FDR-corrected 0.05 threshold.
and replication cohorts. Abbreviations: DE, differentially expressed.3.3. Functional annotation and replication of modules
Gene set enrichment analysis of each module resulted in three
signiﬁcantly enriched gene ontology biological processes per
module in discovery and replication. These enriched GOBP terms
were pooled across all discovery and replication modules and
assigned to eight main GOBP branches: “Organic substance
metabolic process”, “Signal Transduction”, “Transport”, “Regula-
tion of biological process”, “Cellular metabolic process”, “Cellular
component organization”, “Other metabolic processes,” andk-gray pass the 0.1 DE score threshold. Upper score limits (set to maximum of 1) are
The Venn diagram displays the number of overlapping DE genes between the discovery
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9th branch: “Other biological processes”. Table 2 shows the three
GOBP terms for all discovery modules, their respective branches
and category of overlap with the replication modules. Further
details about these branches and overlap can be found in
supplementary Fig. 2.
Combined across all 33 differentially expressed gene modules in
the discovery data set, we identiﬁed 84 GOBP terms (at maximum
three per gene module, see Table 2). For 19 of the 33 discovery
modules, the discovery module overlaps both in genes and GOBP
term with a replication module (overlap category 1), as shown in
Fig. 3. Another eight gene modules overlap a GOBP term with a
replication module, but do not overlap in genes (overlap category
2). Five modules overlapped in genes but did not overlap in GOBP
term with the same replication module (overlap category 3). A
single module did not overlap in either genes or GOBP term with
the replication modules. This result brings the replication results ofFig. 3. Overlap between discovery and replication modules. Each module of discovery is sho
indicate the overlapping number of genes between two modules. Intersections marked in b
indicates the category of overlap for each discovery module (1: overlap in genes and GOBP
term). Abbreviations: GOBP, gene ontology biological process.gene modules with the replication data set at 73% when based on
overlapping genes (category 1 and 3) compared with 82% based on
overlapping GOBP term(s) (category 1 and 2).
3.4. Interaction with AD genes
Of 27 known AD risk genes, 25 were expressed in the brain
tissue that was studied. Three genes (11%) showed a DE score of
0.1: CD2AP (score 0.18), MEF2C (0.29), and PTK2B (0.50); none
of these were assigned to a module. Only MEF2C and PTK2B are
replicated with a DE score of 0.39 and 0.13, respectively. Ten AD
genes interacted at least twicewith a discoverymodule: ABCA7, APP,
BIN1, CELF1, CLU, HLA-DRB1, HLA-DRB5,MAPT, PICALM, and PTK2B, as
shown in Table 2. Six AD genes interacted only once with a dis-
covery module: APOE, CD2AP, INPP5D, MEF2C, PSEN1, and PSEN2.
Nine AD genes did not interact with any discovery module: CASS4,
CD33, CR1, FERMT2, MS4A6A, RIN3, SLC24A4, SORL1, and ZCWPW1.wn horizontally, and the replication modules are shown vertically. The numbers shown
lack indicate modules that share a gene ontology biological process. The last column
term, 2: overlap in GOBP term, but not in genes, 3: overlap in genes, but not in GOBP
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Our study identiﬁed 2716 differentially expressed genes (DE
genes) in hippocampus of 18 AD cases compared with 10 age- and
sex-matched nondemented controls. Of these 2716 DE genes, 735
were clustered in 33 genemodules based on PPI data. These 33 gene
modules were assigned 84 gene ontology biological processes
(GOBP terms, at maximum three for each gene module) which
together comprise nine main GOBP branches. All nine branches
were frequently observed in previous AD studies.
4.1. Replication by gene modules and GOBP terms is more robust
and identiﬁes the most central AD changes
Replication of our results in an independent data set (GSE95587,
fusiform gyrus of 84 AD cases and 33 controls, [van der Brug et al.,
2017]) was based on different categories of overlap, reﬂecting the
robustness of these overlapping processes in the underlying path-
ophysiology of AD. The ﬁnding that most of our gene modules falls
into category 1 (n ¼ 19) indicates that the combined approach of
GOBP annotated and PPI clustered genemodules identiﬁes themost
robust changes in AD gene expression. The gene modules in cate-
gory 2 (n ¼ 8) and category 3 (n ¼ 5) might reﬂect some variability
of gene expression between hippocampus in our study and fusiform
gyrus of AD brains in the replication study.
The present comparative study supports the idea that the
overlapping data sets based on gene modules or GOBP term per
module is more robust than based on overlapping genes only, as the
overlap of all DE genes (48%) can be improved by categorization into
gene modules (72%), and even more by overlap based on GOBP
terms (82%).
4.2. GOBP branches represent common AD pathways
The nine main GOBP branches are previously observed in liter-
ature of AD expression studies (Chi et al., 2016; C.E. Humphries
et al., 2015; Liang et al., 2008; Ray and Zhang, 2010; Sekar et al.,
2015; Twine et al., 2011; Wang et al., 2016). These GOBP branches
can be found in detail, containing all module annotations in
supplemental Table 2.
GOBP branch 1, named “organic substance metabolic process”,
consists of metabolic processes such as DNA replication and repair
and RNA translation and post-translational modiﬁcations. These
metabolic processes underlie many other biological processes and
are dysregulated in AD cases as a response to the various disease-
related changes in the AD hippocampus (C.E. Humphries et al.,
2015; Liang et al., 2008; Sekar et al., 2015; Twine et al., 2011;
Wang et al., 2016). The second GOBP branch, called “signal trans-
duction”, consists of six gene modules that represent the same
distinct neurotransmitter signaling pathways in both the discovery
and replication data sets (all six gene module are in overlap cate-
gory 1). These results indicate a broad dysfunction of synaptic
transmission in the AD brain. These are likely the result of neuronal
degeneration in AD hippocampus and are often found dysregulated
in AD literature (Chi et al., 2016; C.E. Humphries et al., 2015; Liang
et al., 2008; Ray and Zhang, 2010; Sekar et al., 2015; Wang et al.,
2016). GOBP branch 3, enriched for “transport”, mostly represents
ion transport GOBP terms, as shown in supplemental Fig. 2. Many
modules in this GOBP branch are involved in energy production,
which is often described as dysfunctional in previous AD studies
(C.E. Humphries et al., 2015; Wang et al., 2016). These results are
likely caused by neuronal degradation, and thus reduced energy
consumption, although activation of glial cells might also inﬂuence
this process (Sekar et al., 2015). GOBP branch 4 “regulation of bio-
logical processes” is largely complementary to the other GOBPbranches. It contains modules annotated to both an executive bio-
logical process, for example, “transmembrane transport” and its
regulative process, “regulation of transmembrane transport”. Six of
its seven gene modules fall into overlap category 1, indicating a
robust dysfunction in this GOBP branch.
These ﬁrst four GOBP branches are the largest and therefore
underlie changes in AD pathophysiology that stand out the most in
our study. Of the 33 identiﬁed gene modules in our study, 23 are
involved in these four GOBP branches. With 17 gene modules in
overlap category 1, this indicates that these four GOBP branches are
among the most robust changes in AD pathophysiology. Given the
functions of these central GOBP branches, we conclude that organic
substance metabolic processes, neurotransmitter signaling, energy
transport, and regulation of biological processes are main
dysfunctional pathways in AD pathophysiology.
Of the remaining GOBP branch 5 (including RNA splicing and
dephosphorylation), branch 6 (incl axon development), and branch
7 (other metabolic processes), gene modules overlap mostly on in
category 2 and category 3 with the replication data set. These three
GOBP branches do not contain any unique gene modules and are
likely not as robustly involved in AD as the other GOBP branches.
GOBP branch 8, “response to stimulus,” is the smallest GOBP
branch, indicating a response to neurodegeneration resulting in
inﬂammation and glial cell activation which has often been
observed in previous studies (C.E. Humphries et al., 2015; Sekar
et al., 2015; Wang et al., 2016). All three gene modules in GOBP
branch 8 overlapped in category 1 with the replication data set,
suggesting that this small GOBP branch represents a robust change
to AD pathophysiology. The biological processes of GOBP branch 9,
including “neuromuscular process”, “actin-ﬁlament based move-
ment,” and “neuron projection guidance might also be robust
changes in AD, but are represented by only a small number of gene
modules in our data, possibly because of the late stage of the dis-
ease in our samples.4.3. Interactions with AD genes
Of 27 AD genetic risk factor genes, only three were differentially
expressed in our data set, and two replicated (MEF2C and PTK2B).
Several discovery modules interacted with these AD genes, sug-
gesting a degree of overlap in biological function. HLA-DRB1, HLA-
DRB5, BIN1, and PICALM interact with M9 and might be involved in
endocytosis and/or microtubule-basedmovement (Baig et al., 2010;
Zhou et al., 2014). ABCA7 and MAPT interact with a gene module
involved in ion transport and signaling (M2). APP interacts with M1
and is involved in signal transduction (Cheng et al., 2014; Cirrito
et al., 2008). PTK2B is differentially expressed in both discovery
and replication and interacts with modules involved in receptor
signaling and protein modiﬁcation (M7, M10, and M25) (Beecham
et al., 2014; Han et al., 2017). CELF1 interacts with genes involved
in RNA processing and protein modiﬁcation (M8) and CLU interacts
genes involved in exocytosis and actin-based ﬁlament organization
(M14). These interactions suggest roles of these genes also in later
stages of AD and do not represent the typical associations of these
genes in a causal inference (Lambert et al., 2013; Van Cauwenberghe
et al., 2016).4.4. Limitations of this study
This study holds several limitations. First, PPI networks
comprise existing databases, which generate bias to well-known
genes and biological processes (Gillis et al., 2014; Schaefer et al.,
2015; von Mering et al., 2003). Indeed, of the 2716 DE genes
identiﬁed in discovery, only 1610 held an interaction in the STRING
J.G.J. van Rooij et al. / Neurobiology of Aging 74 (2019) 225e233232database, and some relevant genes might have been excluded as a
result.
An important issue in using PPI data for your network analysis is
that there are no clear guidelines on what to use for the interaction
score cutoff, Markov clustering inﬂation factor threshold, or on the
proper functional annotation of modules. Nevertheless, some
consensus is emerging and these most commonly used parameters
were also applied in this study. These parameters are (1) priori-
tizing or limiting to experimental interactions types, or not using
text-mining based types because this minimizes bias of the results
(Szklarczyk et al., 2017; von Mering et al., 2003); (2) optimizing the
MCL inﬂation factor to generate modules of 10e100 genes
(Subramanian et al., 2005; van Dongen and Abreu-Goodger, 2012);
3. replication, preferably on a functional annotation level as gene
ontology (Ashburner et al., 2000; Gene Ontology, 2015).
To optimize clustering of the gene modules, additional metrics
of the generated PPI network could be included, for example, the
direction of effect, or weighting PPI interactions. This study was
designed as a cross-sectional case-control analysis, and many of the
observed differences might be caused by neurodegeneration. Our
sample size of 18 cases and 10 controls is not optimal to robustly
detect all deviations in AD, and some genes/GOBP termsmight have
been missed.
4.5. Conclusions
Our method provides a comprehensive and complete overview
of dysregulation based on GOBPs in AD. We show that the PPI and
MCL clustering approach identiﬁes functional gene modules which
replicate in other data sets. Where individual genes might differ
between studies, overall GOBP terms are preserved and can be
identiﬁed in this manner. Replication based on gene module GOBP
terms was more robust than based on individual genes (82% vs
48%).
Disclosure statement
This work was supported by the Joint Programming Initiative
Neurodegenerative Diseases (JPND) and ZonMW (grant number
[733051022]).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.neurobiolaging.2018.
10.023.
References
Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P.,
Dolinski, K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P., Issel-Tarver, L.,
Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E., Ringwald, M., Rubin, G.M.,
Sherlock, G., 2000. Gene ontology: tool for the uniﬁcation of biology. The Gene
Ontology Consortium. Nat. Genet. 25, 25e29.
Baig, S., Joseph, S.A., Tayler, H., Abraham, R., Owen, M.J., Williams, J., Kehoe, P.G.,
Love, S., 2010. Distribution and expression of picalm in Alzheimer disease.
J. Neuropathol. Exp. Neurol. 69, 1071e1077.
Beecham, G.W., Hamilton, K., Naj, A.C., Martin, E.R., Huentelman, M., Myers, A.J.,
Corneveaux, J.J., Hardy, J., Vonsattel, J.P., Younkin, S.G., Bennett, D.A., De
Jager, P.L., Larson, E.B., Crane, P.K., Kamboh, M.I., Koﬂer, J.K., Mash, D.C.,
Duque, L., Gilbert, J.R., Gwirtsman, H., Buxbaum, J.D., Kramer, P., Dickson, D.W.,
Farrer, L.A., Frosch, M.P., Ghetti, B., Haines, J.L., Hyman, B.T., Kukull, W.A.,
Mayeux, R.P., Pericak-Vance, M.A., Schneider, J.A., Trojanowski, J.Q.,
Reiman, E.M., Alzheimer’s Disease Genetics, C., Schellenberg, G.D., Montine, T.J.,
2014. Genome-wide association meta-analysis of neuropathologic features of
Alzheimer’s disease and related dementias. Plos Genet. 10, e1004606.
Bekris, L.M., Yu, C.E., Bird, T.D., Tsuang, D.W., 2010. Genetics of Alzheimer disease.
J. Geriatr. Psychiatry Neurol. 23, 213e227.
Bolger, A.M., Lohse, M., Usadel, B., 2014. Trimmomatic: a ﬂexible trimmer for Illu-
mina sequence data. Bioinformatics 30, 2114e2120.Boyle, P.A., Wilson, R.S., Yu, L., Barr, A.M., Honer, W.G., Schneider, J.A., Bennett, D.A.,
2013. Much of late life cognitive decline is not due to common neurodegener-
ative pathologies. Ann. Neurol. 74, 478e489.
Braak, H., Braak, E., 1995. Staging of Alzheimer’s disease-related neuroﬁbrillary
changes. Neurobiol. Aging 16, 271e278 discussion 8-84.
Carbon, S., Ireland, A., Mungall, C.J., Shu, S., Marshall, B., Lewis, S., Ami, G.O.H., Web
Presence Working, G., 2009. AmiGO: online access to ontology and annotation
data. Bioinformatics 25, 288e289.
Cheng, X., Wu, J., Geng, M., Xiong, J., 2014. Role of synaptic activity in the regulation
of amyloid beta levels in Alzheimer’s disease. Neurobiol. Aging 35, 1217e1232.
Chi, L.M., Wang, X., Nan, G.X., 2016. In silico analyses for molecular genetic mech-
anism and candidate genes in patients with Alzheimer’s disease. Acta Neurol.
Belg. 116, 543e547.
Cirrito, J.R., Kang, J.E., Lee, J., Stewart, F.R., Verges, D.K., Silverio, L.M., Bu, G.,
Mennerick, S., Holtzman, D.M., 2008. Endocytosis is required for synaptic
activity-dependent release of amyloid-beta in vivo. Neuron 58, 42e51.
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P.,
Chaisson, M., Gingeras, T.R., 2013. STAR: ultrafast universal RNA-seq aligner.
Bioinformatics 29, 15e21.
Enright, A.J., Van Dongen, S., Ouzounis, C.A., 2002. An efﬁcient algorithm for large-
scale detection of protein families. Nucleic Acids Res. 30, 1575e1584.
Gene Ontology, C., 2001. Creating the gene ontology resource: design and imple-
mentation. Genome Res. 11, 1425e1433.
Gene Ontology, C., 2015. Gene ontology consortium: going forward. Nucleic Acids
Res. 43, D1049eD1056.
Gillis, J., Ballouz, S., Pavlidis, P., 2014. Bias tradeoffs in the creation and analysis of
protein-protein interaction networks. J. Proteomics 100, 44e54.
Han, Z., Huang, H., Gao, Y., Huang, Q., 2017. Functional annotation of Alzheimer’s
disease associated loci revealed by GWASs. PLoS One 12, e0179677.
Harrow, J., Frankish, A., Gonzalez, J.M., Tapanari, E., Diekhans, M., Kokocinski, F.,
Aken, B.L., Barrell, D., Zadissa, A., Searle, S., Barnes, I., Bignell, A., Boychenko, V.,
Hunt, T., Kay, M., Mukherjee, G., Rajan, J., Despacio-Reyes, G., Saunders, G.,
Steward, C., Harte, R., Lin, M., Howald, C., Tanzer, A., Derrien, T., Chrast, J.,
Walters, N., Balasubramanian, S., Pei, B., Tress, M., Rodriguez, J.M., Ezkurdia, I.,
van Baren, J., Brent, M., Haussler, D., Kellis, M., Valencia, A., Reymond, A.,
Gerstein, M., Guigo, R., Hubbard, T.J., 2012. GENCODE: the reference human
genome annotation for the ENCODE Project. Genome Res. 22, 1760e1774.
Holtzman, D.M., Carrillo, M.C., Hendrix, J.A., Bain, L.J., Catafau, A.M., Gault, L.M.,
Goedert, M., Mandelkow, E., Mandelkow, E.M., Miller, D.S., Ostrowitzki, S.,
Polydoro, M., Smith, S., Wittmann, M., Hutton, M., 2016. Tau: from research to
clinical development. Alzheimers Dement 12, 1033e1039.
Humphries, C., Kohli, M.A., Whitehead, P., Mash, D.C., Pericak-Vance, M.A., Gilbert, J.,
2015a. Alzheimer disease (AD) speciﬁc transcription, DNA methylation and
splicing in twenty AD associated loci. Mol. Cell Neurosci 67, 37e45.
Humphries, C.E., Kohli, M.A., Nathanson, L., Whitehead, P., Beecham, G., Martin, E.,
Mash, D.C., Pericak-Vance, M.A., Gilbert, J., 2015b. Integrated whole tran-
scriptome and DNA methylation analysis identiﬁes gene networks speciﬁc to
late-onset Alzheimer’s disease. J. Alzheimers Dis. 44, 977e987.
Jellinger, K.A., 2008. Neuropathological aspects of Alzheimer disease, Parkinson
disease and frontotemporal dementia. Neurodegener Dis. 5, 118e121.
Karran, E., Mercken, M., De Strooper, B., 2011. The amyloid cascade hypothesis for
Alzheimer’s disease: an appraisal for the development of therapeutics. Nat. Rev.
Drug Discov. 10, 698e712.
Kavanagh, T., Mills, J.D., Kim, W.S., Halliday, G.M., Janitz, M., 2013. Pathway analysis
of the human brain transcriptome in disease. J. Mol. Neurosci. 51, 28e36.
Kong, W., Mou, X., Zhang, N., Zeng, W., Li, S., Yang, Y., 2015. The construction of
common and speciﬁc signiﬁcance subnetworks of Alzheimer’s disease from
multiple brain regions. Biomed. Res. Int. 2015, 394260.
Kong, W., Zhang, J., Mou, X., Yang, Y., 2014. Integrating gene expression and protein
interaction data for signaling pathway prediction of Alzheimer’s disease.
Comput. Math. Methods Med. 2014, 340758.
Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C.,
DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G., Thorton-
Wells, T.A., Jones, N., Smith, A.V., Chouraki, V., Thomas, C., Ikram, M.A.,
Zelenika, D., Vardarajan, B.N., Kamatani, Y., Lin, C.F., Gerrish, A., Schmidt, H.,
Kunkle, B., Dunstan, M.L., Ruiz, A., Bihoreau, M.T., Choi, S.H., Reitz, C., Pasquier, F.,
Cruchaga, C., Craig, D., Amin, N., Berr, C., Lopez, O.L., De Jager, P.L.,
Deramecourt, V., Johnston, J.A., Evans, D., Lovestone, S., Letenneur, L., Moron, F.J.,
Rubinsztein, D.C., Eiriksdottir, G., Sleegers, K., Goate, A.M., Fievet, N.,
Huentelman, M.W., Gill, M., Brown, K., Kamboh, M.I., Keller, L., Barberger-
Gateau, P., McGuiness, B., Larson, E.B., Green, R., Myers, A.J., Dufouil, C., Todd, S.,
Wallon, D., Love, S., Rogaeva, E., Gallacher, J., St George-Hyslop, P., Clarimon, J.,
Lleo, A., Bayer, A., Tsuang, D.W., Yu, L., Tsolaki, M., Bossu, P., Spalletta, G.,
Proitsi, P., Collinge, J., Sorbi, S., Sanchez-Garcia, F., Fox, N.C., Hardy, J., Deniz
Naranjo, M.C., Bosco, P., Clarke, R., Brayne, C., Galimberti, D., Mancuso, M.,
Matthews, F., European Alzheimer’s Disease, I., Genetic, Environmental Risk in
Alzheimer’s, D., Alzheimer’s Disease Genetic, C., Cohorts for, H., Aging Research
in Genomic, E., Moebus, S., Mecocci, P., Del Zompo, M., Maier, W., Hampel, H.,
Pilotto, A., Bullido, M., Panza, F., Caffarra, P., Nacmias, B., Gilbert, J.R.,
Mayhaus, M., Lannefelt, L., Hakonarson, H., Pichler, S., Carrasquillo, M.M.,
Ingelsson, M., Beekly, D., Alvarez, V., Zou, F., Valladares, O., Younkin, S.G.,
Coto, E., Hamilton-Nelson, K.L., Gu, W., Razquin, C., Pastor, P., Mateo, I.,
Owen, M.J., Faber, K.M., Jonsson, P.V., Combarros, O., O’Donovan, M.C.,
Cantwell, L.B., Soininen, H., Blacker, D., Mead, S., Mosley Jr., T.H., Bennett, D.A.,
Harris, T.B., Fratiglioni, L., Holmes, C., de Bruijn, R.F., Passmore, P., Montine, T.J.,
J.G.J. van Rooij et al. / Neurobiology of Aging 74 (2019) 225e233 233Bettens, K., Rotter, J.I., Brice, A., Morgan, K., Foroud, T.M., Kukull, W.A.,
Hannequin, D., Powell, J.F., Nalls, M.A., Ritchie, K., Lunetta, K.L., Kauwe, J.S.,
Boerwinkle, E., Riemenschneider, M., Boada, M., Hiltuenen, M., Martin, E.R.,
Schmidt, R., Rujescu, D., Wang, L.S., Dartigues, J.F., Mayeux, R., Tzourio, C.,
Hofman, A., Nothen, M.M., Graff, C., Psaty, B.M., Jones, L., Haines, J.L.,
Holmans, P.A., Lathrop, M., Pericak-Vance, M.A., Launer, L.J., Farrer, L.A., van
Duijn, C.M., Van Broeckhoven, C., Moskvina, V., Seshadri, S., Williams, J.,
Schellenberg, G.D., Amouyel, P., 2013. Meta-analysis of 74,046 individuals
identiﬁes 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45,
1452e1458.
Liang, W.S., Dunckley, T., Beach, T.G., Grover, A., Mastroeni, D., Ramsey, K.,
Caselli, R.J., Kukull, W.A., McKeel, D., Morris, J.C., Hulette, C.M., Schmechel, D.,
Reiman, E.M., Rogers, J., Stephan, D.A., 2008. Altered neuronal gene expression
in brain regions differentially affected by Alzheimer’s disease: a reference data
set. Physiol. Genomics 33, 240e256.
Liao, Y., Smyth, G.K., Shi, W., 2014. featureCounts: an efﬁcient general purpose
program for assigning sequence reads to genomic features. Bioinformatics 30,
923e930.
McCarthy, D.J., Chen, Y., Smyth, G.K., 2012. Differential expression analysis of
multifactor RNA-Seq experiments with respect to biological variation. Nucleic
Acids Res. 40, 4288e4297.
Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S.,
Hughes, J.P., van Belle, G., Berg, L., 1991. The consortium to establish a registry
for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic
assessment of Alzheimer’s disease. Neurology 41, 479e486.
Morris, J.H., Apeltsin, L., Newman, A.M., Baumbach, J., Wittkop, T., Su, G., Bader, G.D.,
Ferrin, T.E., 2011. clusterMaker: a multi-algorithm clustering plugin for Cyto-
scape. BMC Bioinformatics 12, 436.
Murray, M.E., Graff-Radford, N.R., Ross, O.A., Petersen, R.C., Duara, R., Dickson, D.W.,
2011. Neuropathologically deﬁned subtypes of Alzheimer’s disease with distinct
clinical characteristics: a retrospective study. Lancet Neurol. 10, 785e796.
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., Kanehisa, M., 1999. KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 27, 29e34.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C.P., 2013. The global
prevalence of dementia: a systematic review and metaanalysis. Alzheimers
Dement 9, 63e75.e2.
Ray, M., Zhang, W., 2010. Analysis of Alzheimer’s disease severity across brain re-
gions by topological analysis of gene co-expression networks. BMC Syst. Biol. 4,
136.
Robinson, M.D., McCarthy, D.J., Smyth, G.K., 2010. edgeR: a Bioconductor package for
differential expression analysis of digital gene expression data. Bioinformatics
26, 139e140.
Schaefer, M.H., Serrano, L., Andrade-Navarro, M.A., 2015. Correcting for the study
bias associated with protein-protein interaction measurements reveals differ-
ences between protein degree distributions from different cancer types. Front
Genet. 6, 260.
Scheltens, P., Blennow, K., Breteler, M.M., de Strooper, B., Frisoni, G.B., Salloway, S.,
Van der Flier, W.M., 2016. Alzheimer’s disease. Lancet 388, 505e517.Sekar, S., McDonald, J., Cuyugan, L., Aldrich, J., Kurdoglu, A., Adkins, J., Serrano, G.,
Beach, T.G., Craig, D.W., Valla, J., Reiman, E.M., Liang, W.S., 2015. Alzheimer’s
disease is associated with altered expression of genes involved in immune
response and mitochondrial processes in astrocytes. Neurobiol. Aging 36,
583e591.
Selkoe, D.J., Hardy, J., 2016. The amyloid hypothesis of Alzheimer’s disease at 25
years. EMBO Mol. Med. 8, 595e608.
Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.L., Ideker, T., 2011. Cytoscape 2.8: new
features fordata integrationandnetworkvisualization. Bioinformatics27,431e432.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A.,
Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., 2005. Gene set
enrichment analysis: a knowledge-based approach for interpreting genome-
wide expression proﬁles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545e15550.
Sutherland, G.T., Janitz, M., Kril, J.J., 2011. Understanding the pathogenesis of Alz-
heimer’s disease: will RNA-Seq realize the promise of transcriptomics?
J. Neurochem. 116, 937e946.
Szklarczyk, D., Morris, J.H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A.,
Doncheva, N.T., Roth, A., Bork, P., Jensen, L.J., von Mering, C., 2017. The STRING
database in 2017: quality-controlled protein-protein association networks,
made broadly accessible. Nucleic Acids Res. 45, D362eD368.
Thal, D.R., Attems, J., Ewers, M., 2014. Spreading of amyloid, tau, and microvascular
pathology in Alzheimer’s disease: ﬁndings from neuropathological and neuro-
imaging studies. J. Alzheimers Dis. 42 (Suppl 4), S421eS429.
Tomiyama, T., 2010. Involvement of beta-amyloid in the etiology of Alzheimer’s
disease. Brain Nerve 62, 691e699.
Twine, N.A., Janitz, K., Wilkins, M.R., Janitz, M., 2011. Whole transcriptome
sequencing reveals gene expression and splicing differences in brain regions
affected by Alzheimer’s disease. PLoS One 6, e16266.
Van Cauwenberghe, C., Van Broeckhoven, C., Sleegers, K., 2016. The genetic land-
scape of Alzheimer disease: clinical implications and perspectives. Genet. Med.
18, 421e430.
van der Brug, H., Huntly, M., Cao, Y., 2017. Heterogeneity in neurodegenerative
disease (GSE95587). NCBI GEO.
van Dongen, S., Abreu-Goodger, C., 2012. Using MCL to extract clusters from net-
works. Methods Mol. Biol. 804, 281e295.
von Mering, C., Huynen, M., Jaeggi, D., Schmidt, S., Bork, P., Snel, B., 2003. STRING: a
database of predicted functional associations between proteins. Nucleic Acids
Res. 31, 258e261.
Wang, M., Roussos, P., McKenzie, A., Zhou, X., Kajiwara, Y., Brennand, K.J., De
Luca, G.C., Crary, J.F., Casaccia, P., Buxbaum, J.D., Ehrlich, M., Gandy, S., Goate, A.,
Katsel, P., Schadt, E., Haroutunian, V., Zhang, B., 2016. Integrative network
analysis of nineteen brain regions identiﬁes molecular signatures and networks
underlying selective regional vulnerability to Alzheimer’s disease. Genome
Med. 8, 104.
Zhou, Y., Hayashi, I., Wong, J., Tugusheva, K., Renger, J.J., Zerbinatti, C., 2014. Intra-
cellular clusterin interacts with brain isoforms of the bridging integrator 1 and
with the microtubule-associated protein Tau in Alzheimer’s disease. PLoS One 9,
e103187.
